Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
492
2.630
 Why?
Thrombolytic Therapy
4
2022
111
1.300
 Why?
Pneumonia, Viral
6
2020
168
1.300
 Why?
Fibrinolytic Agents
4
2022
125
1.290
 Why?
Coronavirus Infections
6
2020
178
1.280
 Why?
Tissue Plasminogen Activator
3
2020
110
1.260
 Why?
Endovascular Procedures
2
2022
169
0.850
 Why?
Pandemics
8
2020
554
0.840
 Why?
Cavernous Sinus
1
2022
15
0.810
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
11
0.800
 Why?
Conflict of Interest
2
2020
25
0.740
 Why?
Embolization, Therapeutic
1
2022
87
0.740
 Why?
Iodine Compounds
1
2020
7
0.720
 Why?
Brain Edema
1
2020
41
0.700
 Why?
Brain Ischemia
4
2022
161
0.650
 Why?
Mucopolysaccharidosis II
1
2018
1
0.650
 Why?
Contrast Media
1
2020
183
0.650
 Why?
Cardiology
1
2020
89
0.650
 Why?
Medicare
1
2020
244
0.640
 Why?
Coronary Angiography
1
2020
336
0.630
 Why?
Physicians
1
2020
234
0.570
 Why?
Hospitalization
6
2022
653
0.510
 Why?
Databases, Factual
3
2020
664
0.430
 Why?
Telemedicine
1
2019
443
0.430
 Why?
Humans
29
2022
49827
0.420
 Why?
Headache
2
2022
76
0.370
 Why?
Aged
10
2021
9272
0.370
 Why?
Time Factors
4
2020
2912
0.360
 Why?
Autoimmune Diseases
2
2020
100
0.340
 Why?
Ischemic Attack, Transient
2
2020
56
0.340
 Why?
Immunosuppressive Agents
2
2020
220
0.330
 Why?
United States
6
2020
4838
0.310
 Why?
Female
16
2021
26329
0.290
 Why?
Male
14
2021
25093
0.280
 Why?
Arkansas
4
2019
1967
0.270
 Why?
Middle Aged
11
2021
11997
0.260
 Why?
Emergency Service, Hospital
2
2020
488
0.260
 Why?
Tomography, X-Ray Computed
2
2020
1159
0.230
 Why?
Triage
2
2021
64
0.230
 Why?
Thrombectomy
2
2020
66
0.220
 Why?
Drug Industry
2
2020
38
0.220
 Why?
Neuroimaging
2
2020
82
0.220
 Why?
Critical Care
2
2021
201
0.200
 Why?
Retrospective Studies
5
2020
6117
0.200
 Why?
Sinus Thrombosis, Intracranial
1
2021
17
0.190
 Why?
Myasthenia Gravis
1
2021
17
0.190
 Why?
Hospitalists
1
2020
11
0.190
 Why?
Intracranial Thrombosis
1
2020
16
0.190
 Why?
Ageusia
1
2020
6
0.180
 Why?
Olfaction Disorders
1
2020
7
0.180
 Why?
Neuromuscular Diseases
1
2020
30
0.180
 Why?
Osmolar Concentration
1
2020
62
0.180
 Why?
Health Services Misuse
1
2020
13
0.180
 Why?
Multiple Sclerosis
1
2020
65
0.180
 Why?
Lymphoma, Non-Hodgkin
1
2020
62
0.180
 Why?
Health Care Sector
1
2020
15
0.180
 Why?
Time-to-Treatment
1
2020
62
0.180
 Why?
Neurologic Examination
1
2020
77
0.180
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.180
 Why?
Mood Disorders
1
2020
59
0.180
 Why?
Young Adult
2
2020
3936
0.170
 Why?
Patient Transfer
1
2020
95
0.170
 Why?
Brain Diseases
1
2020
82
0.170
 Why?
Venous Thrombosis
1
2020
91
0.170
 Why?
Subarachnoid Hemorrhage
1
2020
65
0.170
 Why?
Drug-Eluting Stents
1
2020
93
0.170
 Why?
Suicidal Ideation
1
2020
96
0.170
 Why?
Recombinant Fusion Proteins
1
2010
182
0.170
 Why?
Fabry Disease
1
2019
9
0.170
 Why?
Enzyme Replacement Therapy
1
2019
17
0.170
 Why?
Fluorocarbons
1
2019
45
0.170
 Why?
Hospitals
1
2020
175
0.170
 Why?
Nervous System Diseases
1
2020
88
0.170
 Why?
Tomography Scanners, X-Ray Computed
1
2018
12
0.160
 Why?
Aged, 80 and over
3
2020
3125
0.160
 Why?
Angiography, Digital Subtraction
1
2018
27
0.160
 Why?
Angiogenesis Inhibitors
1
2010
187
0.160
 Why?
Neuroprotective Agents
1
2019
105
0.160
 Why?
Seizures
1
2020
196
0.160
 Why?
Anxiety
1
2020
269
0.160
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
130
0.150
 Why?
Pain
1
2020
380
0.150
 Why?
Meningitis
1
2016
24
0.140
 Why?
Referral and Consultation
1
2019
287
0.140
 Why?
Diagnosis, Differential
1
2020
1036
0.140
 Why?
Myocardial Infarction
1
2020
382
0.140
 Why?
Antibodies, Monoclonal
1
2010
458
0.130
 Why?
Percutaneous Coronary Intervention
1
2020
299
0.130
 Why?
Ovarian Neoplasms
1
2010
448
0.130
 Why?
Plasma Cells
1
2016
223
0.130
 Why?
Magnetic Resonance Imaging
2
2020
1533
0.120
 Why?
Adult
5
2020
13160
0.120
 Why?
RNA-Directed DNA Polymerase
1
2002
6
0.110
 Why?
Oligodeoxyribonucleotides
1
2002
31
0.110
 Why?
DNA, Complementary
1
2002
135
0.100
 Why?
Adolescent
2
2020
6340
0.100
 Why?
Antineoplastic Agents
1
2010
1172
0.100
 Why?
Mycobacterium tuberculosis
1
2002
280
0.090
 Why?
Treatment Outcome
4
2022
5138
0.090
 Why?
Intubation, Intratracheal
2
2021
118
0.090
 Why?
Cohort Studies
2
2022
1422
0.070
 Why?
Prevalence
2
2020
943
0.070
 Why?
Risk Factors
2
2022
3619
0.050
 Why?
Intracranial Hemorrhages
1
2022
39
0.050
 Why?
Multiple Myeloma
1
2016
2910
0.050
 Why?
Cerebral Hemorrhage
1
2022
104
0.050
 Why?
Cranial Sinuses
1
2021
10
0.050
 Why?
Industry
1
2020
17
0.050
 Why?
Arthritis, Psoriatic
1
2020
9
0.050
 Why?
Spondylitis, Ankylosing
1
2020
9
0.050
 Why?
Cranial Nerves
1
2020
14
0.050
 Why?
Disease Susceptibility
1
2021
89
0.050
 Why?
Endocrine System Diseases
1
2010
10
0.050
 Why?
Colitis, Ulcerative
1
2020
50
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
 Why?
Mortality
1
2020
99
0.040
 Why?
Arthritis, Rheumatoid
1
2020
105
0.040
 Why?
Registries
1
2022
518
0.040
 Why?
Crohn Disease
1
2020
89
0.040
 Why?
Maximum Tolerated Dose
1
2019
37
0.040
 Why?
Administration, Oral
1
2020
423
0.040
 Why?
Tertiary Care Centers
1
2019
77
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
68
0.040
 Why?
Disease Outbreaks
1
2020
125
0.040
 Why?
Disability Evaluation
1
2019
87
0.040
 Why?
Hemorrhage
1
2020
202
0.040
 Why?
Skin Diseases
1
2010
111
0.040
 Why?
Gastrointestinal Diseases
1
2010
126
0.040
 Why?
Electronic Health Records
1
2021
205
0.040
 Why?
Drug Administration Schedule
1
2019
376
0.040
 Why?
Recovery of Function
1
2019
189
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
222
0.040
 Why?
Comorbidity
1
2019
618
0.040
 Why?
Patient Readmission
1
2019
222
0.040
 Why?
Double-Blind Method
1
2019
674
0.040
 Why?
Prognosis
1
2022
1952
0.040
 Why?
Fatal Outcome
1
2016
195
0.030
 Why?
Follow-Up Studies
1
2020
2179
0.030
 Why?
Risk Assessment
1
2019
1262
0.030
 Why?
Prospective Studies
1
2020
2344
0.030
 Why?
Cardiovascular Diseases
1
2010
440
0.030
 Why?
Cross-Sectional Studies
1
2019
1541
0.030
 Why?
DNA Primers
1
2002
206
0.030
 Why?
Infant
1
2020
3551
0.030
 Why?
Child, Preschool
1
2020
3853
0.020
 Why?
Transcription, Genetic
1
2002
371
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
412
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
188
0.020
 Why?
RNA, Messenger
1
2002
1105
0.020
 Why?
Child
1
2020
6824
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (151) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department